516 related articles for article (PubMed ID: 18082181)
1. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
Stöckl M; Fischer P; Wanker E; Herrmann A
J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
[TBL] [Abstract][Full Text] [Related]
2. Helical alpha-synuclein forms highly conductive ion channels.
Zakharov SD; Hulleman JD; Dutseva EA; Antonenko YN; Rochet JC; Cramer WA
Biochemistry; 2007 Dec; 46(50):14369-79. PubMed ID: 18031063
[TBL] [Abstract][Full Text] [Related]
3. Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR.
Ramakrishnan M; Jensen PH; Marsh D
Biochemistry; 2006 Mar; 45(10):3386-95. PubMed ID: 16519533
[TBL] [Abstract][Full Text] [Related]
4. Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein.
Smith DP; Tew DJ; Hill AF; Bottomley SP; Masters CL; Barnham KJ; Cappai R
Biochemistry; 2008 Feb; 47(5):1425-34. PubMed ID: 18179253
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles.
Zhu M; Qin ZJ; Hu D; Munishkina LA; Fink AL
Biochemistry; 2006 Jul; 45(26):8135-42. PubMed ID: 16800638
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein association with phosphatidylglycerol probed by lipid spin labels.
Ramakrishnan M; Jensen PH; Marsh D
Biochemistry; 2003 Nov; 42(44):12919-26. PubMed ID: 14596606
[TBL] [Abstract][Full Text] [Related]
7. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
[TBL] [Abstract][Full Text] [Related]
8. Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing.
van Rooijen BD; Claessens MM; Subramaniam V
FEBS Lett; 2008 Nov; 582(27):3788-92. PubMed ID: 18930058
[TBL] [Abstract][Full Text] [Related]
9. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
Choi W; Zibaee S; Jakes R; Serpell LC; Davletov B; Crowther RA; Goedert M
FEBS Lett; 2004 Oct; 576(3):363-8. PubMed ID: 15498564
[TBL] [Abstract][Full Text] [Related]
10. Visualization of lipid domain-specific protein sorting in giant unilamellar vesicles.
Stöckl M; Nikolaus J; Herrmann A
Methods Mol Biol; 2010; 606():115-26. PubMed ID: 20013394
[TBL] [Abstract][Full Text] [Related]
11. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
[TBL] [Abstract][Full Text] [Related]
12. Spin-label EPR on alpha-synuclein reveals differences in the membrane binding affinity of the two antiparallel helices.
Drescher M; Godschalk F; Veldhuis G; van Rooijen BD; Subramaniam V; Huber M
Chembiochem; 2008 Oct; 9(15):2411-6. PubMed ID: 18821550
[TBL] [Abstract][Full Text] [Related]
13. Probing conformational change of intrinsically disordered α-synuclein to helical structures by distinctive regional interactions with lipid membranes.
Lee SJ; Lee JW; Choi TS; Jin KS; Lee S; Ban C; Kim HI
Anal Chem; 2014 Feb; 86(3):1909-16. PubMed ID: 24383916
[TBL] [Abstract][Full Text] [Related]
14. Locally resolved membrane binding affinity of the N-terminus of α-synuclein.
Robotta M; Hintze C; Schildknecht S; Zijlstra N; Jüngst C; Karreman C; Huber M; Leist M; Subramaniam V; Drescher M
Biochemistry; 2012 May; 51(19):3960-2. PubMed ID: 22494024
[TBL] [Abstract][Full Text] [Related]
15. Membrane-bound structure and energetics of alpha-synuclein.
Mihajlovic M; Lazaridis T
Proteins; 2008 Feb; 70(3):761-78. PubMed ID: 17729279
[TBL] [Abstract][Full Text] [Related]
16. Membrane bound α-synuclein is fully embedded in the lipid bilayer while segments with higher flexibility remain.
Wietek J; Haralampiev I; Amoussouvi A; Herrmann A; Stöckl M
FEBS Lett; 2013 Aug; 587(16):2572-7. PubMed ID: 23831067
[TBL] [Abstract][Full Text] [Related]
17. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
Kumar S; Sarkar A; Sundar D
Biochem Biophys Res Commun; 2009 Sep; 387(2):305-9. PubMed ID: 19580781
[TBL] [Abstract][Full Text] [Related]
18. A triple-emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type alpha-synuclein and its familial Parkinson's disease mutants.
Celej MS; Caarls W; Demchenko AP; Jovin TM
Biochemistry; 2009 Aug; 48(31):7465-72. PubMed ID: 19586054
[TBL] [Abstract][Full Text] [Related]
19. Binding of Cu(II) to human alpha-synucleins: comparison of wild type and the point mutations associated with the familial Parkinson's disease.
Hong L; Simon JD
J Phys Chem B; 2009 Jul; 113(28):9551-61. PubMed ID: 19548659
[TBL] [Abstract][Full Text] [Related]
20. GM1 specifically interacts with alpha-synuclein and inhibits fibrillation.
Martinez Z; Zhu M; Han S; Fink AL
Biochemistry; 2007 Feb; 46(7):1868-77. PubMed ID: 17253773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
